Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Articles Health & Fitness Cancer
Premium Member
Novel Research: Optimized Car-T Design Locally Activates Small-Molecule Cancer Drugs

CAR-T-cell therapy is a type of immunotherapy that fights cancer by using specifically engineered T cells. T cells from a patient's blood are taken and modified to develop specific structures on their...

Candy Swift Feb 06, 2022
Premium Member
Antibody-Mediated Adcc and Cdc–Taking Rituximab As an Example

In the fight against disease, two types of immune actions have provided an escalating engine for the development of antibody-based pharmaceuticals: antibody-dependent cell-mediated cytotoxicity (ADCC...

Candy Swift Feb 06, 2022
Premium Member
Oncolytic Virus & Bacteria Therapy: a New Era of Cancer Treatment at Dawn

Cancer is the leading cause of death and illness in humans. However, the advancement of life science and technology, as well as the advancement of medical knowledge, has resulted in significant...

Candy Swift Dec 29, 2021
Premium Member
Bispecific Antibody: Next Big Thing in Oncology Treatment

The US Food and Drug Administration (FDA) authorized the first monoclonal antibody to treat cancer in 1997, ushering in a new age of therapies for patients. Human monoclonal antibody therapies are...

Candy Swift Dec 27, 2021
Premium Member
Cd33-Targeted Bispecific Antibodies: an Emerging Therapy for Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a genetically heterogeneous disease characterized by the clonal expansion of leukemic cells. Despite a better understanding of the biology of AML and the recent...

Candy Swift Dec 01, 2021
Premium Member
Oncolytic Virotherapy for Tumor Treatment: Challenges and Solutions

Immunotherapy has shown to be a viable treatment option for a variety of cancers in recent decades. Among a variety of immunotherapies, oOncolytic viruses (OVs), which could be designed to proliferate...

Candy Swift Nov 30, 2021
Premium Member
An Introduction to Act Family: Til, Tcr-T, Car-T, and Car-Nk

With the advancement of science and technology, many medical challenges are gradually being overcome. For hematological malignancies, the most popular treatment is CAR-T (chimeric antigen receptor T...

Candy Swift Nov 30, 2021
Premium Member
A High-Salt Diet May Induce Effective Tumor Immunity-I

A high-salt diet is defined as consuming more than 6 grams of salt per day. We've always believed that this diet is more dangerous than beneficial, so we strive to eat as little salt as possible on a...

Jerry Carter Nov 04, 2021
Premium Member
This Gene is Shown to Be Overexpressed in 70% of Cancers! How Far Away is the First Therapy?

MYC mutations are among the most common in human cancers and can not only cause cancer in normal cells but also help cancer cells escape the immune response. MYC protein, on the other hand, is a...

Jerry Carter Nov 04, 2021
Premium Member
Scientists Discover Gene Therapy Might Be an Option for Glaucoma

Glaucoma is a leading cause of vision impairment and blindness, affecting 76 million patients worldwide. The optic nerve is made of more than a million tiny nerve fibers. It is like an electric cable...

Candy Swift Nov 02, 2021
Premium Member
Opportunities and Obstacles of Therapeutic Cancer Vaccine

Vaccines are undoubtedly one of the most landmark inventions in the history of human development. Since the world's first cowpox vaccine was developed in 1976, humans have been working on various...

Candy Swift Oct 07, 2021
Premium Member
Cancer Cell: Barrier to Cancer Immunotherapy Discovered

Stanniocalcin-1 (STC1) is a glycoprotein hormone involved in calcium/phosphate homeostasis that regulates a variety of cellular processes during normal development and tumorigenesis. Aft

Jerry Carter Oct 04, 2021
Premium Member
Cancer Immunotherapy Overview

In the Journal of Controlled Release, Vol. 336, 2021, Islam A. Khalil's research group from the Misr University for Science and Technology (Egypt) published a review article titled "Cancer...

Jerry Carter Oct 04, 2021
Premium Member
The 12Th Adc Drug Approved by the Fda

Seagne and Genmab announced on September 20, 2021 that Tisotumab Vedotin has received accelerated approval from the FDA for the treatment of recurring or metastatic cervical cancer.Tivdak (Tisotumab...

Jerry Carter Oct 04, 2021
Premium Member
Car-T Goes Hot: Laser Pulses-Heated Car-T Cells Show Better Efficiency

CAR T-cell therapy has been lauded as a feasible solution for several cancers by patients, clinical researchers, investors, and the media. As a fact, it is now one of the most intriguing research...

Candy Swift Aug 31, 2021
Prior 1 2 3 4 5 . . . 56